BACK TO TOP
KSE100
150,398.71
-1612.55
(-1.06%)
KSE100PR
46,388.18
-497.36
(-1.06%)
ALLSHR
90,084.08
-849.88
(-0.93%)
KSE30
45,453.35
-522.50
(-1.14%)
KMI30
218,271.12
-2019.44
(-0.92%)
BKTI
41,775.33
-317.96
(-0.76%)
OGTI
31,328.41
-192.61
(-0.61%)
KMIALLSHR
58,965.48
-483.69
(-0.81%)
PSXDIV20
69,275.99
-334.22
(-0.48%)
UPP9
53,604.91
-816.58
(-1.50%)
NITPGI
40,257.92
-498.35
(-1.22%)
NBPPGI
43,748.19
-479.03
(-1.08%)
MZNPI
26,730.49
-291.55
(-1.08%)
JSMFI
37,917.79
-476.50
(-1.24%)
ACI
18,983.47
-270.39
(-1.40%)
JSGBKTI
63,313.69
-103.24
(-0.16%)
HBLTTI
18,159.28
02-04-2026
9.06
(0.05%)
MII30
19,753.63
-217.18
(-1.09%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.324.30
-1.44
(-0.44%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Apr 3, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
315.00
High
329.48
Low
315.00
Volume
218,962
CIRCUIT BREAKER
293.17 — 358.31
DAY RANGE
315.00 — 329.48
52-WEEK RANGE ^
293.09 — 481.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
325.74
VAR
14.50
HAIRCUT
17.50
P/E Ratio (TTM) **
10.30
1-Year Change * ^
-22.53%
YTD Change * ^
-16.80%
Last update: Fri, Apr 3, 2026 4:35 PM
Open
327.00
High
327.00
Low
323.90
Close
323.93
Change
-1.45%
LDCP
328.71
Volume
3,500
Total Trades
5
CIRCUIT BREAKER
295.84 — 361.58
DAY RANGE
323.90 — 327.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
103,278,938.26
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 26, 2026Financial Results for the year Ended 2025-12-31 View   PDF
Oct 29, 2025Transmission of Quarterly Report for the period ended September 30, 2025 View   PDF
Oct 24, 2025Financial Results for the Quarter ended September 30, 2025 View   PDF
Aug 29, 2025Transmission of Half Yearly Report for the Period ended June 30, 2025 View   PDF
Aug 26, 2025Financial Results for the Quarter ended June 30, 2025 View   PDF
DateTitleDocument
Mar 18, 2026Board Meeting Quarter 4, 2025 View   PDF
Oct 16, 2025Notice of Board of Directors Meeting (Q3-2025) View   PDF
Aug 19, 2025Notice of Board of Directors Meeting (Q2- 2025) View   PDF
Apr 28, 2025Certified True Copy of the Resolutions passed by shareholders in the Annual General Meeting held on April 28, 2025 View   PDF
Apr 17, 2025Board Meeting Quarter ended March 31, 2025 View   PDF
DateTitleDocument
Mar 31, 2026Material Information View   PDF
Dec 5, 2025Presentation for Corporate Briefing Session -2025 View   PDF
Dec 3, 2025Notice of Corporate Briefing Session - 2025 View   PDF
Sep 19, 2025Credit of Interim cash dividend View   PDF
Sep 2, 2025Notice of interim cash dividend and share book closure View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales65,900,90161,187,50149,661,27741,841,585
Profit after Taxation10,025,3156,536,047533,9532,462,892
EPS31.4820.521.687.73
Q3 2025Q2 2025Q1 2025Q3 2024
Sales14,188,00814,720,66715,580,14014,730,940
Profit after Taxation2,037,2852,068,8112,126,5471,927,134
EPS6.406.506.686.05
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)37.0025.157.0517.40
Net Profit Margin (%)15.2110.681.085.89
EPS Growth (%)53.411,121.43(78.27)(54.02)
PEG0.230.02(0.63)(0.21)

Payouts

Financial Reports